Vitamin K-containing dietary supplements: Comparison of synthetic vitamin K1 and natto-derived menaquinone-7

Blood

Volumn 109, Issue 8, 2007, Pages 3279-3283

  Schurgers, Leon J ^a   Teunissen, Kirsten J F ^a   Hamulyák, Karly ^b   Knapen, Marjo H J ^a   Vik, Hogne ^c   Vermeer, Cees ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NattoPharma ASA   (Norway)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7; MENAQUINONE; MENAQUINONE 7; OSTEOCALCIN; PHYTOMENADIONE; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOXYLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 34147137917     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-08-040709     Document Type: Article

References (23)

1. Berkner KL, Runge KW. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost. 2004;2:2118-2132.
2. Stafford DW. The vitamin K cycle. J Thromb Haemost. 2005;3:1873-1878.
3. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care. 2000;3:433-438.
4. Szulc P, Arlot M, Chapuy M-C, et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 1994;9:1591-1595.
5. Knapen MHJ, Nieuwenhuijzen Kruseman AC, Wouters RSME, Vermeer C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int. 1998;63:375-379.
6. Szulc P, Chapuy M-C, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91:1769-1774.
7. Luukinen H, Käkönen S-M, Petterson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res. 2000;15:2473-2478.
8. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of vitamin K-2 reduces the risk of cardiac events and aortic atherosclerosis: The Rotterdam Study. J Nutr. 2004;134:3100-3105.
9. 1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int. 2003;73:21-26.
10. Braam LAJLM, Hoeks APG, Brouns F, et al. Beneficial effects of vitamin K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost. 2004;91: 373-380.
11. Vermeer C, Shearer MJ, Zittermann A, et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr. 2004;43:1-11.
12. Shearer MJ, Bolton-Smith C. The U.K. food database for vitamin K and why we need it. Food Chem. 2000;68:213-218.
13. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food: effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000;30:298-307.
14. 1 (phylloquinone) content of foods: a provisional table. J Food Comp Anal. 1993;6:109-120.
15. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002;1570:27-32.
16. Kaneki M, Hedges SJ, Hosoi T, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition. 2001;17:315-321.
17. Suzuki Y, Kondo K, Ichise H, et al. Dietary supplementation with fermented soybeans suppress intimal thickening. Nutrition. 2003;19:261-264.
18. Katsuyama H, Ideguchi S, Fukunaga M, et al. Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women. J Nutr Sci Vitaminol. 2004;50:114-120.
19. 1 in low birth-weight neonates. Dev Pharmacol Ther. 1985;8:269-279.
20. Camilo ME, Jatoi A, O'Brien M, et al. Bioavailability of phylloquinone from an intravenous lipid emulsion. Am J Clin Nutr. 1998;67:716-721.
21. 3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim Biophys Acta. 1990;1034:170-175.
22. Schurgers LJ, Shearer MJ, Hamulyák K, et al. Effect of vitamin K on the stability of oral anticoagulant treatment: dose response relationship in healthy subjects. Blood. 2004;104:2682-2689.
23. Sokoll LJ, Booth SL, O'Brien ME, et al. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr. 1997;65:779-784.